genocea biosciences inc
(GNCA:Consolidated Issue listed on NASDAQ Global Market)
Kevin J. Bitterman Ph.D.
Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee, Genocea Biosciences, Inc.
|Age||Total Calculated Compensation||This person is connected to 58 board members in 7 different organizations across 9 different industries.|
See Board Relationships
Dr. Kevin J. Bitterman, Ph.D. is a Partner at Polaris Partners since April 2014. Dr. Bitterman joined Polaris Partners in July 2004 and focuses on investments in the life sciences. He is a Board Observer to Arsenal Medical and 480 Biomedical. He served as an Interim Chief Executive Officer and Interim President at Editas Medicine Inc. until June 24, 2014. He was a founding Chief Executive Officer at the firm. He is a Director at the firm. He was a Co-Founder of Sirtris ...
100 Acorn Park DrivePhone: 617-876-8191
Cambridge, Massachusetts 02140
Board Members Memberships*
Former Board Observer
Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
Rutgers, The State University of New Jersey
Harvard Medical School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|